APEX1 and acute myeloid leukemia: Of interest, the inhibition of Ref-1 with APX3330, APX2009, and APX2014 was sufficient to inhibit vasculature mimicry in both the Tsc2−/− MEFs and 621-102 AML cells, while mTORC1 inhibition with rapamycin was not effective at the analyzed doses.